Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: Pharmacoepidemiol Drug Saf. 2023 Jan 4;32(5):577–585. doi: 10.1002/pds.5591

Table 3.

Comparison of sensitivity and specificity of OUD algorithm and ICD codes from the main analysis to that from the sensitivity analyses

Main analyses Exclude iteration 1 OUD only where both reviewers agreea OUD only if at least four DSM criteria were met
Stage 3 Se (95% CI) 23.04% (22.64-23.44) 24.60% (24.08-25.12) 25.12% (24.58-25.66) 26.90% (26.39-27.51)
Sp (95% CI) 98.36% (98.32-98.40) 98.64% (98.60-98.69) 97.51% (97.47-97.56) 97.35% (97.30-97.40)
ICD at stage 3 Se (95% CI) 10.34% (10.10-10.59) 12.24% (11.92-12.55) 11.75% (11.44-12.06) 17.09% (16.65-17.53)
Sp (95% CI) 99.54% (99.52-99.57) 99.64% (99.62-99.67) 99.17% (99.14-99.21) 99.21% (99.18-99.24)
Stage 4 Se (95% CI) 16.37% (16.03-16.71) 17.13% (16.70-17.55) 14.41% (14.00-14.82) 15.53% (15.07-15.99)
Sp (95% CI) 98.55% (98.51-98.59) 98.74% (98.70-98.78) 97.73% (97.68-97.78) 97.67% (97.63-97.72)
ICD at stage 4 Se (95% CI) 10.11% (9.86-10.37) 11.35% (11.04-11.66) 12.07% (11.73-12.41) 15.67% (15.24-16.11)
Sp (95% CI) 99.66% (99.64-99.68) 99.63% (99.60-99.65) 99.33% (99.30-99.36) 99.35% (99.32-99.37)

Abbreviations: Se – sensitivity; Sp – specificity; OUD – opioid use disorder; ICD – international classification of diseases; DSM – Diagnostic and Statistical Manual of Mental Disorders.

a

– This applies only to cases where two reviewers reviewed a case – if both reviewers considered the case to be OUD then the case was considered to be OUD; if one reviewer considered the case to be OUD and another didn’t, OR both reviewers considered the case to be non-OUD, then the case was considered to be non-OUD; if only one reviewer reviewed the case, then that reviewer’s adjudication was considered as it is.